5月7日中银创新医疗混合C净值下跌3.58%，近1个月累计上涨17.34%

Group 1 - The core point of the news is the performance and holdings of the Zhongyin Innovation Medical Mixed Fund C, which has shown significant returns over various time frames despite a recent decline in net value [1] - As of May 7, 2025, the latest net value of the fund is 1.6149 yuan, reflecting a decrease of 3.58%. The fund has achieved a return of 17.34% over the past month, ranking 231 out of 4587 in its category [1] - The fund's performance over the last three months has been strong, with a return of 34.96%, ranking 16 out of 4535, and a year-to-date return of 36.23%, ranking 31 out of 4494 [1] Group 2 - The top ten stock holdings of the Zhongyin Innovation Medical Mixed Fund C account for a total of 70.44%, with significant positions in companies such as Kelun-Botai (9.77%), Hengrui Medicine (9.39%), and Innovent Biologics (8.54%) [1] - The fund was established on October 30, 2020, and as of March 31, 2025, it has a total scale of 1.454 billion yuan, managed by fund manager Zheng Ning [1]